These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35209915)

  • 1. Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis.
    Peng P; Yang Y; Du J; Zhai K; Shi HZ
    Cancer Cell Int; 2022 Feb; 22(1):99. PubMed ID: 35209915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis.
    Yang Y; Du J; Wang YS; Kang HY; Zhai K; Shi HZ
    Clin Transl Sci; 2022 Jun; 15(6):1340-1354. PubMed ID: 35212454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
    Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
    Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of survivin in malignant pleural effusion: a meta-analysis.
    Chen S; Wang Y; An L; Fei ZT; Li T
    Clin Chim Acta; 2015 Feb; 441():142-7. PubMed ID: 25559946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.
    Yoshimura A; Yamada T; Tsuji T; Hamashima R; Shiotsu S; Yuba T; Takumi C; Uchino J; Hiraoka N; Takayama K
    Thorac Cancer; 2019 Mar; 10(3):557-563. PubMed ID: 30672656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment.
    Wang TF; Chu SC; Lee JJ; Yang GG; Huang WH; Chang ET; Low T; Wu YF; Kao RH; Lin CB
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):304-313. PubMed ID: 28124437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.
    Tian P; Shen Y; Wan C; Yang T; An J; Yi Q; Chen L; Wang T; Wang Y; Wen F
    Int J Clin Exp Pathol; 2014; 7(9):5880-7. PubMed ID: 25337230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions.
    Fafliora E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Physiol Rep; 2016 Dec; 4(24):. PubMed ID: 28039396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
    Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
    Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians.
    Wong C; Wing-Cheuk Wong R; Kit-Ying So L; Yin-Chun Yam L
    Respir Med; 2021; 189():106650. PubMed ID: 34688123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
    BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.
    Rathore SS; Hussain N; Manju AH; Wen Q; Tousif S; Avendaño-Capriles CA; Hernandez-Woodbine MJ; Rojas GA; Vatsavayi P; Tera CR; Ali MA; Singh R; Saleemi S; Patel DM
    J Med Virol; 2022 Jan; 94(1):229-239. PubMed ID: 34449896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for benign and malignant hydrothorax.
    Gu Y; Zhang M; Li GH; Gao JZ; Guo L; Qiao XJ; Wang LH; He L; Wang ML; Yan L; Fu XH
    Chin Med J (Engl); 2015 Feb; 128(3):305-9. PubMed ID: 25635424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
    Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
    Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Prognostic CT Findings for Patients With Advanced Lung Adenocarcinoma Receiving First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy.
    Chang S; Hur J; Hong YJ; Lee HJ; Kim YJ; Han K; Choi BW
    AJR Am J Roentgenol; 2018 Jan; 210(1):43-51. PubMed ID: 29091002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Prognostic Role of Pleural Effusion in Patients with Pulmonary Embolism: A Systematic Review and Meta-Analysis.
    Li P; An J; Wang S; Hu X; Zeng T; Wan C; Shen Y; Wang T
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.
    Shen YC; Liu MQ; Wan C; Chen L; Wang T; Wen FQ
    Exp Ther Med; 2012 Jun; 3(6):1072-1076. PubMed ID: 22970019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
    Psallidas I; Kanellakis NI; Gerry S; Thézénas ML; Charles PD; Samsonova A; Schiller HB; Fischer R; Asciak R; Hallifax RJ; Mercer R; Dobson M; Dong T; Pavord ID; Collins GS; Kessler BM; Pass HI; Maskell N; Stathopoulos GT; Rahman NM
    Lancet Oncol; 2018 Jul; 19(7):930-939. PubMed ID: 29908990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.